Prophylactic Intravenous Tranexamic Acid on Perioperative Blood Loss in Pregnant Women Undergoing Cesarean Section
Trial statusNot yet recruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexFemale
Age18+
SponsorChulalongkorn University
About this trial
The purpose of this study is to asses the effect of preoperative prophylactic intravenous tranexamic acid on perioperative blood loss in pregnant women undergoing cesarean section
Eligibility criteria
Qualifiers
pregnant women with gestational age 37-42 weeks
undergoing cesarean delivery with indication as follows: placenta previa, severe preeclampsia, myoma uteri, fetal macrosomia, polyhydramnios, grand multiparity ≥ 5 deliveries, prolonged labor, etc.
Disqualifiers
history of allergy to tranexamic acid
history of venous thromboembolism (Deep vein thrombosis, Pulmonary embolism)
history of arterial thrombosis (Myocardial infarction, Stroke)
history of seizure, convulsion
Trial design
Treatments tested in this trial
- Tranexamic Acid
- Placebo
Treatment groups
98 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov